Apollo Therapeutics raised $33.5m in an extended Series C funding led by Patient Square Capital, joined by M&G and Rock Springs Capital.

Biotech Manufacturing Pharma

United Kingdom

United States

Investments

03 December 2023

Share:

Apollo Therapeutics (company)

United Kingdom

Biotech Manufacturing Pharma

Total investments received (USD): 260m

Round value (USD): 33.5m

Round investors: M&G Investments Patient Square Capital Rock Springs Capital

Company: Apollo Therapeutics

Industry: Biotech Manufacturing Pharma

Related deals

Pathios Therapeutics raised $25m in Series B funding from Bristol Myers Squibb, Canaan and Brandon Capital.

Biotech Health services Manufacturing

United Kingdom

Australia

United States

Israel

Investments 07 April 2024

Theolytics raised £19m in funding from Sound Bioventures, M Ventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises.

Biotech Health services Pharma

United Kingdom

United States

Netherlands

Japan

Sweden

Investments 07 April 2024

EnteroBiotix secures £27m funding w/ Thairm Bio, Kineticos Life Sciences, The Scottish National Investment Bank, Scottish Enterprise.

Biotech Health services Manufacturing

United Kingdom

United States

Investments 05 March 2024

Relation Therapeutics raises $35 million seed extension from NVentures, DCVC, Deerfield Management, Khosla Ventures, ARK Invest and Magnetic Ventures.

Biotech Health services Manufacturing Pharma

United Kingdom

United States

Investments 04 March 2024

Enterprise Therapeutics to raise £26M series B with Panakes Partners, Versant Ventures, Novartis Venture Fund, IP Group, Forbion Capital, Epidarex Capital

Health services Manufacturing Pharma

United Kingdom

United States

Netherlands

Switzerland

Italy

Investments 04 January 2024